Literature DB >> 22676937

Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction.

Franck Thuny1, Olivier Lairez, François Roubille, Nathan Mewton, Gilles Rioufol, Catherine Sportouch, Ingrid Sanchez, Cyrille Bergerot, Hélène Thibault, Thien Tri Cung, Gérard Finet, Laurent Argaud, Didier Revel, Geneviève Derumeaux, Eric Bonnefoy-Cudraz, Meier Elbaz, Christophe Piot, Michel Ovize, Pierre Croisille.   

Abstract

OBJECTIVES: This study aimed to determine whether post-conditioning at the time of percutaneous coronary intervention could reduce reperfusion-induced myocardial edema in patients with acute ST-segment elevation myocardial infarction (STEMI).
BACKGROUND: Myocardial edema is a reperfusion injury with potentially severe consequences. Post-conditioning is a cardioprotective therapy that reduces infarct size after reperfusion, but no previous studies have analyzed the impact of this strategy on reperfusion-induced myocardial edema in humans.
METHODS: Fifty patients with STEMI were randomly assigned to either a control or post-conditioned group. Cardiac magnetic resonance imaging was performed within 48 to 72 h after admission. Myocardial edema was measured by T2-weighted sequences, and infarct size was determined by late gadolinium enhancement sequences and creatine kinase release.
RESULTS: The post-conditioned and control groups were similar with respect to ischemia time, the size of the area at risk, and the ejection fraction before percutaneous coronary intervention. As expected, post-conditioning was associated with smaller infarct size (13 ± 7 g/m(2) vs. 21 ± 14 g/m(2); p = 0.01) and creatine kinase peak serum level (median [interquartile range]: 1,695 [1,118 to 3,692] IU/l vs. 3,505 [2,307 to 4,929] IU/l; p = 0.003). At reperfusion, the extent of myocardial edema was significantly reduced in the post-conditioned group as compared with the control group (23 ± 16 g/m(2) vs. 34 ± 18 g/m(2); p = 0.03); the relative increase in T2W signal intensity was also significantly lower (p = 0.02). This protective effect was confirmed after adjustment for the size of the area at risk.
CONCLUSIONS: This randomized study demonstrated that post-conditioning reduced infarct size and edema in patients with reperfused STEMI.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22676937     DOI: 10.1016/j.jacc.2012.03.026

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  54 in total

1.  The clinical impact of sex differences on ischemic postconditioning during primary percutaneous coronary intervention: a POST (the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction) substudy.

Authors:  Eun-Seok Shin; Ju-Hyun Chung; Joo-Yong Hahn; Young Bin Song; Eun Kyoung Kim; Cheol Woong Yu; Jang-Whan Bae; Woo-Young Chung; Seung-Hyuk Choi; Jin-Ho Choi; Jang-Ho Bae; Kyung Joo An; Jong-Seon Park; Ju Hyeon Oh; Sang-Wook Kim; Jin-Yong Hwang; Jae Kean Ryu; Scot Garg; Do-Sun Lim; Hyeon-Cheol Gwon; Hun Sik Park
Journal:  Heart Vessels       Date:  2018-12-05       Impact factor: 2.037

2.  Acute coronary syndromes: Postconditioning reduces myocardial edema.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

3.  The neuroimmune guidance cue netrin-1: a new therapeutic target in cardiovascular disease.

Authors:  Bongo Bertrand Joseph; Peng Dao Quan
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

4.  Interventional cardiology: ischaemic POSTconditioning-a long harvest for a little corn.

Authors:  Michel Ovize; Nathan Mewton
Journal:  Nat Rev Cardiol       Date:  2013-11-12       Impact factor: 32.419

Review 5.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial.

Authors:  Eun Kyoung Kim; Joo-Yong Hahn; Young Bin Song; Sang-Chol Lee; Jin-Ho Choi; Seung-Hyuk Choi; Sang Hoon Lee; Yeon Hyeon Choe; Hyeon-Cheol Gwon
Journal:  Int J Cardiovasc Imaging       Date:  2015-01-15       Impact factor: 2.357

Review 7.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

Review 8.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

9.  Regional heterogeneity in cardiac sympathetic innervation in acute myocardial infarction: relationship with myocardial oedema on magnetic resonance.

Authors:  Alessia Gimelli; Pier Giorgio Masci; Riccardo Liga; Chrysanthos Grigoratos; Emilio Maria Pasanisi; Massimo Lombardi; Paolo Marzullo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-13       Impact factor: 9.236

Review 10.  Imaging the myocardial microcirculation post-myocardial infarction.

Authors:  Steven K White; Derek J Hausenloy; James C Moon
Journal:  Curr Heart Fail Rep       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.